HPV Vaccine Protecting Against Cervical Cancer

Until recently, the other cancers caused by HPV were less common than cervical cancer. According to the National Cancer Institute, the incidence of HPV-positive throat and tongue cancer has been increasing. Approximately 70 percent of tongue and throat cancers are caused by HPV. In the United States, noncervical cancers caused by HPV are now as common as cervical cancers and mostly occur in men. There are no formal screening programs for noncervical cancers associated with HPV, so vaccination can provide a public benefit. Also, the HPV vaccine was originally only recommended for boys and girls ages 11 to 26. In 2018, the U.S. Food and Drug Administration approved the expanded use of the HPV vaccine Gardasil 9 used in the U.S. It is now recommended that men and women ages 27 to 45 receive the vaccination as well.

Source : https://santamariatimes.com/lifestyles/health-med-fit/your-cancer-answers/kim-neace-protecting-against-cervical-cancer/article_5425ff2c-6cd7-5136-8df1-9a4b10e7e186.html

Kim Neace: Protecting against cervical cancer
Malawi launches HPV vaccine campaign: Minister Muluzi says cervical cancer leading cause of women’s deaths
Vaccine, Screening Can Prevent Cervical Cancer Deaths
Cervical Cancer Awareness Month: ‘We are winning the battle’
If You Didn't Get the HPV Vaccine Before Age 26, You May Be Eligible to Get It Now
Good News: Women Up to Age 45 Are Now Eligible for the HPV Vaccine
Preventing Cervical Cancer: January Is National Cervical Cancer Awareness Month
China Focus: Chinese researchers develop breakthrough vaccine against cervical cancer
Scientists develop breakthrough vaccine against cervical cancer